1. Partnership to Promote Next-Generation Diagnostic Test for CF
Read about a partnership to simplify the adoption of next-generation DNA sequencing for routine diagnostic laboratories. According to the terms of the agreement, Sophia Genetics will use its advanced analytical platform, Sophia DDM, to support Devyser’s NGS diagnostic kits for cystic fibrosis and hereditary breast cancer.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?